Thomas d’Aquin Toni

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Eugene L. Asahchop, Maureen Oliveira, Mark A. Wainberg et al. · Antimicrobial Agents and Chemotherapy · 2010 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 Study

Ahidjo Ayouba, Truong Thi Xuan Lien, Janin Nouhin et al. · AIDS Research and Human Retroviruses · 2009 · 48 citations

Life Sciences, Infectious Diseases, Microbiology +17

Presence of Key Drug Resistance Mutations in Isolates from Untreated Patients of Abidjan, Côte d'Ivoire: ANRS 1257 Study

Thomas d’Aquin Toni, Patrícia Recordon-Pinson, Albert Minga et al. · AIDS Research and Human Retroviruses · 2003 · 44 citations

Life Sciences, Infectious Diseases, Molecular Genetics +17

Susceptibility to Antiretroviral Drugs of CRF01_AE, CRF02_AG, and Subtype C Viruses from Untreated Patients of Africa and Asia: Comparative Genotypic and Phenotypic Data

Hervé Fleury, Thomas d’Aquin Toni, Nguyen Thi Hoang Lan et al. · AIDS Research and Human Retroviruses · 2006 · 36 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults

Christine Danel, Raoul Moh, Marie‐Laure Chaix et al. · The Journal of Infectious Diseases · 2008 · 36 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17